GLAXO · GlaxoSmithKline Pakistan Limited
GlaxoSmithKline Pakistan Board Meeting Notice for Q3 2026 Financial Results
Official PSX filing title: Board Meeting Quarter 3-2026
- Filed
- 21 October 2026 at 11:17 am
- Category
- Meetings
- Sentiment
- Neutral
- Impact
- Low
Executive summary
GlaxoSmithKline Pakistan Limited has announced that its Board of Directors will meet on October 29, 2026, to consider the financial results for the quarter ended September 30, 2026. A closed period is in effect from October 22, 2026, to October 29, 2026.
Key takeaways
- Board meeting scheduled for October 29, 2026 at 12:00 noon
- Will consider financial results for the quarter ended September 30, 2026
- Closed period set from October 22, 2026 to October 29, 2026
Filing details
Board meeting
- Status
- Scheduled
- Meeting date
- 29 October 2026 at 12:00 pm
- Purpose
- Consideration of quarterly financial results and announcement of closed period
- Venue
- Karachi
- Closed period
- 22 October 2026 – 29 October 2026
- Consideration of the Financial Results of the Company for the quarter ended September 30, 2026
- #board meeting
- #financial results
- #quarterly results
- #closed period
Please cross-check with the official PSX filing before making an investment decision.